NCI operational task order
Ended Awarded Last action
- Contract number
- 75N91020F00003
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,775,380,496
Award facts
- Contract value 100% obligated
- $1,782,759,517.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$10,806 | |
| Funding Only Action | $0 | |
| Other Administrative Action | $29,234,640 | |
| Funding Only Action | $33,374,328 | |
| Funding Only Action | -$11,366,887 | |
| Other Administrative Action | $7,359,436 | |
| Other Administrative Action | $40,094,642 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $57,991,599 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $621,412 | |
| Other Administrative Action | $184,814 | |
| Other Administrative Action | $53,739 | |
| Funding Only Action | $238,382,107 | |
| Exercise an Option | $69,102,452 | |
| Other Administrative Action | $7,688,748 | |
| Funding Only Action | $19,391,416 | |
| Funding Only Action | $12,900,000 | |
| Funding Only Action | $15,100,600 | |
| Funding Only Action | $28,845,070 | |
| Funding Only Action | $61,155,563 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $226,662,708 | |
| Exercise an Option | $63,802,858 | |
| Funding Only Action | $15,797,534 | |
| Other Administrative Action | $21,210,428 | |
| Funding Only Action | $27,442,800 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $59,982,927 | |
| Other Administrative Action | -$1,590,212 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $205,696,815 | |
| Other Administrative Action | -$1,414,661 | |
| Exercise an Option | $90,840,235 | |
| Other Administrative Action | $24,886,601 | |
| Funding Only Action | $16,620,261 | |
| Other Administrative Action | $36,226,692 | |
| Other Administrative Action | $2,626,906 | |
| Funding Only Action | $75,021,989 | |
| Other Administrative Action | $800,000 | |
| Other Administrative Action | $1,283,576 | |
| Other Administrative Action | $400,000 | |
| Funding Only Action | $207,226,867 | |
| Other Administrative Action | $0 | |
| Original award | $91,753,299 |
Show all 46
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on August 31, 2020, with a ceiling value of $1.78 billion. This is a call against the NCI Operational Task Order vehicle (FY20–FY23).
Place of performance is Frederick, MD. Leidos Biomedical Research Inc. operates as a Federally Funded Research and Development Center (FFRDC) contractor providing comprehensive biomedical research and facilities support services to NCI and the National Institutes of Health.
Under this cost-plus-fixed-fee delivery order, actual government-invoiced labor in FY2024 totaled $328.6 million, supporting 1,528 FTEs across 3,178,882 contractor hours at a blended derived rate of $103.36 per hour. The order carried 81 subcontractors accounting for 19 percent of contractor hours. Year-over-year invoiced amounts trended downward in FY2024 after peaking at $470.7 million in FY2023; the derived hourly rate declined sharply from $150.59 in FY2023 to $103.36 in FY2024, reflecting cost adjustments or labor-mix composition changes.
Quick answers
Who was awarded contract 75N91020F00003?
75N91020F00003 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2020.
How much is contract 75N91020F00003 worth?
The government has obligated $1,775,380,496 on 75N91020F00003. Its current value, with exercised options, is $1,782,759,517.
Is contract 75N91020F00003 an order under another contract?
Yes. 75N91020F00003 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91020F00003 competed?
The extent of competition for 75N91020F00003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award